DE69127619D1 - Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck - Google Patents

Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck

Info

Publication number
DE69127619D1
DE69127619D1 DE69127619T DE69127619T DE69127619D1 DE 69127619 D1 DE69127619 D1 DE 69127619D1 DE 69127619 T DE69127619 T DE 69127619T DE 69127619 T DE69127619 T DE 69127619T DE 69127619 D1 DE69127619 D1 DE 69127619D1
Authority
DE
Germany
Prior art keywords
optionally
ketanserin
inhibitors
combinations
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69127619T
Other languages
English (en)
Inventor
Ciro Costagliola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69127619D1 publication Critical patent/DE69127619D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Devices For Medical Bathing And Washing (AREA)
DE69127619T 1991-07-12 1991-12-20 Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck Expired - Lifetime DE69127619D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910519A IT1249678B (it) 1991-07-12 1991-07-12 Collirio per il trattamento della ipertensione oculare

Publications (1)

Publication Number Publication Date
DE69127619D1 true DE69127619D1 (de) 1997-10-16

Family

ID=11400263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127619T Expired - Lifetime DE69127619D1 (de) 1991-07-12 1991-12-20 Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck

Country Status (5)

Country Link
EP (1) EP0522226B1 (de)
JP (1) JPH0525047A (de)
AT (1) ATE157872T1 (de)
DE (1) DE69127619D1 (de)
IT (1) IT1249678B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0813878B1 (de) * 1996-06-17 2002-02-06 Mitsubishi Chemical Corporation Mittel zur Beschleunigung des Tränenflusses enthaltend einen Serotonin-Liganden, insbesondere Aminoalkoxybibenzyle
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
KR20010073153A (ko) 1998-09-18 2001-07-31 제임스 에이. 아노 녹내장 치료용의 세로토닌성 5ｈｔ2 작용제
CA2469663A1 (en) 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
WO2004009586A1 (en) 2002-07-19 2004-01-29 Biovitrum Ab Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
AU2005221283C1 (en) * 2004-03-17 2011-02-03 Lars Michael Larsen Prevention of retinopathy by inhibition of the visual cycle
IT201600072000A1 (it) * 2016-07-11 2018-01-11 Luigi Ambrosone Collirio a base di liposomi e suo uso per la valutazione in vivo dell'efficacia farmacologica della terapia medica e chirurgica anti-glaucoma
SE2250051A1 (en) * 2022-01-20 2023-07-21 Amidea Sweden Ab New pharmaceutical composition and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146077T1 (de) * 1986-09-22 1996-12-15 Janssen Pharmaceutica Nv Serotonin-antagonisten zur behandlung von wunden
WO1991002527A1 (en) * 1989-08-21 1991-03-07 Beth Israel Hospital Association Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists

Also Published As

Publication number Publication date
ATE157872T1 (de) 1997-09-15
ITRM910519A0 (it) 1991-07-12
ITRM910519A1 (it) 1993-01-12
JPH0525047A (ja) 1993-02-02
IT1249678B (it) 1995-03-09
EP0522226B1 (de) 1997-09-10
EP0522226A1 (de) 1993-01-13

Similar Documents

Publication Publication Date Title
EP0371728B1 (de) Wässrige Augenlösung und Verfahren zur Konservierung derselben
Lynch et al. Salinity stress increases cytoplasmic Ca activity in maize root protoplasts
RU2004134733A (ru) Агенты, которые регулируют, ингибируют или модулируют активность и/или экспрессию факторов роста соединительной ткани (фрст), в качестве уникальных средств для снижения внутриглазного давления и лечения глаукоматозных ретинопатий/оптических невропатий
US4551461A (en) Soft contact lens ambient temperature disinfectant and rinsing solution and method
US5215991A (en) Combination of selective alpha-adrenergic agonists and Na+ /H+ ex
ATE265856T1 (de) Augenlösung mit tetracyclin für behandlung von trockenen augen
CA2339093A1 (en) Cholinergic agents in the treatment of presbyopia
US4594091A (en) Borate algaecide and fungicide
DE69127619D1 (de) Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck
RU2003101320A (ru) Композиции, содержащие терапевтически активные компоненты, обладающие повышенной растворимостью
ATE202921T1 (de) Ophtalmische zubereitung niedriger viskosität
TR199901468T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� guanidinil heterosikl bile�ikleri.
US5131938A (en) Borate algaecide and fungicide
WO1998005365A3 (en) Compositions and methods for disinfecting contact lenses and preserving contact lens care products
EP0320980A1 (de) Verwendung eines Mittels zur Sterilisation von Kontaktlinsen und Methode zur Sterilisation von Kontaktlinsen
EP0189405A1 (de) Entkeimung von kontaktlinsen.
EP0114333B1 (de) Pharmazeutische Zusammensetzung
US4390542A (en) Method for inhibiting contraction of opthalmic wounds or incisions
CA1246457A (en) Method of treating cardiac insufficiency
EP1276510B1 (de) Farbiges ophthalmisches produkt
RU2009120545A (ru) Модуляторы связывания pai-1 для лечения глазных болезней
ATE181829T1 (de) Gaba-erge modulation des augenwachstums
US5256660A (en) Synthetic buffer composition for clinical use
HU209538B (en) Set and cleaning composition for treating contactlenses
EP1522321B1 (de) Verfahren zur Desinfektion und/oder Reinigung von Kontaktlinsen unter Verwendung einer wässrigen Lösung enthaltend wenigstens einen Bestandteil der Aloe Vera Pflanze

Legal Events

Date Code Title Description
8332 No legal effect for de